There is no news to report at this time.
Protalix chairman resigns for health reasons (AP) AP - Protalix Biotherapeutics Inc., a pharmaceutical company, said Tuesday its chairman of the board is resigning to recover from an illness.
Generic drugmaker Teva names Frost as chairman (AP) AP - Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board.
Franchisees suing Cardinal Health over agreements (AP) AP - Medicine Shoppe and Medicap pharmacists in seven states sued Cardinal Health in federal court Tuesday, alleging the health care products distributor failed to make good on promises it made when it asked them to switch to a new franchise agreement.
Merck, Sanofi combining animal medicine businesses (AP)
AP - Two of the world's biggest pharmaceutical companies said Tuesday they are uniting their animal health businesses in a deal to become the top dog in the veterinary industry.
WuXi PharmaTech moves to 4th-quarter profit (AP) AP - WuXi PharmaTech Inc. late Monday said it shifted to a profit in the fourth quarter, compared with a year-ago period when the research and development outsourcing company lost money due to a large impairment charge.
Merck, Sanofi to unite animal medicine businesses (AP) AP - PET MEDS: Two top pharmaceutical companies, Merck & Co. and Sanofi-Aventis SA, are uniting their animal health businesses in what would be the world's largest veterinary medicine company.
Tenn. federal judge won't dismiss jaw injury cases (AP) AP - A federal judge in Nashville has refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause severe deterioration of the jaw.
ImmunoGen cancer drug gets 'orphan drug' status (AP) AP - ImmunoGen Inc. said Monday the Food and Drug Administration and European regulators gave the company's potential cancer drug IMGN901 "orphan drug" status.
Acura, King cite positive study on pain drug (AP) AP - Acura Pharmaceuticals Inc. and King Pharmaceuticals Inc. said Monday the potential abuse-resistant painkiller Acurox met key goals in a pivotal study.
ISTA says FDA to review eye drug by Oct. 16 (AP) AP - ISTA Pharmaceuticals Inc. said Monday the Food and Drug Administration will make a regulatory decision on the once-daily eye inflammation treatment XiDay by Oct. 16.
Culver letter prompts Wellmark to delay rate hike (AP) AP - Iowa's largest health insurance provider will delay a planned premium increase after Gov. Chet Culver raised questions Monday about the higher rates to the state insurance commissioner.
Obama targets insurers, sells reform plan (Reuters)
Reuters - President Barack Obama launched a sharp attack on health insurers on Monday and called on his fellow Democrats to rise above politics and pass a healthcare overhaul in the next few weeks.
Nabi closes license deal with GlaxoSmithKline (AP) AP - Nabi Pharmaceuticals said Monday it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline.
Roche suspends arthritis drug study after deaths (AP) AP - Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections.
AIG sells Alico unit to MetLife for $15.5 billion (AP)
AP - American International Group Inc. said Monday that it will sell its American Life Insurance Co. division for $15.5 billion to MetLife Inc. The government-approved deal, AIG's second big asset sale in two weeks, will give the insurer more cash to repay the billions of bailout dollars it still owes the government.
Astra's colon cancer drug fails test (AP) AP - AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG's Avastin in tests for use as an initial treatment against colon cancer.
Drugmakers boost consumer ad spending 2 pct in '09 (AP) AP - Pharmaceutical companies boosted their spending on ads directly targeting consumers by barely 2 percent last year, according to data compiled by The Nielsen Co.
AMAG Anemia Drug Eyes Growing Market (Investor's Business Daily) Investor's Business Daily - Most biotech firms bet their future on only one drug. AMAG Pharmaceuticals (NMS:AMAG) is no exception.
Romney hits Obama for bashing insurance companies (Reuters) Reuters - Potential Republican presidential candidate Mitt Romney criticized President Barack Obama on Friday for his recent attacks on health insurance companies.
White House cranks up pressure for health reform (Reuters)
Reuters - The White House ratcheted up its push for a quick healthcare vote in the U.S. Congress on Thursday, criticizing rising health insurance premiums at a meeting with top industry executives and wooing key lawmakers.
Loaded at: 3/10/2010 4:29:36 AM